193 related articles for article (PubMed ID: 6339343)
1. Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
Descos L; Gauthier A; Levy VG; Michel H; Quinton A; Rueff B; Fermanian J; Fombonne E; Durbec JP
Hepatogastroenterology; 1983 Feb; 30(1):15-20. PubMed ID: 6339343
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
[No Abstract] [Full Text] [Related]
3. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Fuller RK; Khambatta PB; Gobezie GC
JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
[TBL] [Abstract][Full Text] [Related]
5. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
Arroyo V; Ginès P; Planas R
Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
[TBL] [Abstract][Full Text] [Related]
6. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
[TBL] [Abstract][Full Text] [Related]
7. Refractory ascites: definition and mechanism.
Arroyo V; Badalamenti S; Ginès P
Minerva Med; 1987 May; 78(10):675-80. PubMed ID: 3587714
[No Abstract] [Full Text] [Related]
8. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
9. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.
Quintero E; Ginés P; Arroyo V; Rimola A; Bory F; Planas R; Viver J; Cabrera J; Rodés J
Lancet; 1985 Mar; 1(8429):611-2. PubMed ID: 2857949
[TBL] [Abstract][Full Text] [Related]
10. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of ascites in liver cirrhosis].
Gramkow M; Christensen E
Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
Lennhoff M; Duhalt R; Peña JC
Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
[No Abstract] [Full Text] [Related]
13. [Reasons for diuretic therapy of cirrhotic ascites].
Parlapiano C; Paoletti V
Minerva Med; 1985 Nov; 76(43):2043-6. PubMed ID: 3934593
[TBL] [Abstract][Full Text] [Related]
14. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Ginés P; Arroyo V; Quintero E; Planas R; Bory F; Cabrera J; Rimola A; Viver J; Camps J; Jiménez W
Gastroenterology; 1987 Aug; 93(2):234-41. PubMed ID: 3297907
[TBL] [Abstract][Full Text] [Related]
15. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
[TBL] [Abstract][Full Text] [Related]
16. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
17. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
Bianchi Porre G; Lazzaroni M; Petrillo M
Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
[No Abstract] [Full Text] [Related]
18. [Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].
Zhu YF; Gu XB; Zhu HY; Yang XJ; Wang D; Yu P
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):50-3. PubMed ID: 23855131
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
[TBL] [Abstract][Full Text] [Related]
20. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
Iwasa M; Ishihara T; Kato M; Isoai A; Kobayashi R; Torii N; Soneda N; Takei Y
Intern Med; 2019 Nov; 58(21):3069-3075. PubMed ID: 31292400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
